Create Medic Co., Ltd. (TYO:5187)

Create Medic Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	5,636	5,830	6,317	4,392	4,305	4,359
Cash & Short-Term Investments	5,636	5,830	6,317	4,392	4,305	4,359
Cash Growth	19.71%	-7.71%	43.83%	2.02%	-1.24%	9.72%
Receivables	3,222	3,330	3,157	3,424	3,518	3,552
Inventory	4,347	4,487	3,921	4,314	3,848	3,218
Other Current Assets	435	575	545	592	457	446
Total Current Assets	13,640	14,222	13,940	12,722	12,128	11,575
Property, Plant & Equipment	4,869	4,709	4,843	5,389	5,162	5,080
Long-Term Investments	1,158	706	660	495	610	459
Other Intangible Assets	367	418	532	565	636	686
Long-Term Deferred Tax Assets	104	86	71	85	327	274
Other Long-Term Assets	2	2	1	2	2	1
Total Assets	20,140	20,143	20,047	19,258	18,865	18,075

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	362	700	783	787	806	683
Accrued Expenses	48	68	65	68	114	74
Short-Term Debt	-	-	800	800	800	800
Current Income Taxes Payable	96	66	83	84	129	118
Other Current Liabilities	1,093	1,189	1,374	1,228	967	898
Total Current Liabilities	1,599	2,023	3,105	2,967	2,816	2,573
Long-Term Debt	749	749	-	-	-	-
Pension & Post-Retirement Benefits	865	602	836	1,004	1,136	1,202
Long-Term Deferred Tax Liabilities	374	354	261	216	-	-
Other Long-Term Liabilities	66	84	95	128	190	80
Total Liabilities	3,653	3,812	4,297	4,315	4,142	3,855

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,461	1,461	1,461	1,461	1,461	1,461
Additional Paid-In Capital	1,487	1,486	1,486	1,486	1,486	1,486
Retained Earnings	11,501	11,476	11,078	10,586	10,871	10,931
Treasury Stock	-1,622	-1,197	-1,003	-506	-509	-513
Comprehensive Income & Other	3,660	3,105	2,728	1,916	1,414	855
Shareholders' Equity	16,487	16,331	15,750	14,943	14,723	14,220
Total Liabilities & Equity	20,140	20,143	20,047	19,258	18,865	18,075

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	749	749	800	800	800	800
Net Cash (Debt)	4,887	5,081	5,517	3,592	3,505	3,559
Net Cash Growth	3.80%	-7.90%	53.59%	2.48%	-1.52%	15.51%
Net Cash Per Share	534.86	574.85	625.97	394.63	385.25	391.31
Filing Date Shares Outstanding	8.02	8.39	8.57	9.06	9.1	9.09
Total Common Shares Outstanding	8.02	8.39	8.59	9.1	9.1	9.09
Working Capital	12,041	12,199	10,835	9,755	9,312	9,002
Book Value Per Share	2056.50	1947.62	1833.59	1641.44	1618.03	1563.52
Tangible Book Value	16,120	15,913	15,218	14,378	14,087	13,534
Tangible Book Value Per Share	2010.72	1897.77	1771.66	1579.38	1548.13	1488.09
Order Backlog	-	536.89	535.03	551.39	593.32	473.06

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 6, 2026

Data Sources Report a data error